Arvin Capital Management LP cut its stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 26.0% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 42,700 shares of the semiconductor company’s stock after selling 15,000 shares during the period. Synopsys makes up 3.8% of Arvin Capital Management LP’s holdings, making the stock its 13th largest position. Arvin Capital Management LP’s holdings in Synopsys were worth $21,068,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Alpine Bank Wealth Management grew its holdings in shares of Synopsys by 89.3% during the third quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock worth $26,000 after buying an additional 25 shares in the last quarter. TFC Financial Management Inc. boosted its position in Synopsys by 1,250.0% during the 3rd quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company’s stock worth $27,000 after acquiring an additional 50 shares during the last quarter. Millstone Evans Group LLC bought a new position in shares of Synopsys during the 3rd quarter worth approximately $27,000. SOA Wealth Advisors LLC. acquired a new stake in shares of Synopsys in the third quarter valued at approximately $28,000. Finally, McIlrath & Eck LLC acquired a new stake in shares of Synopsys in the third quarter valued at approximately $29,000. Institutional investors and hedge funds own 85.47% of the company’s stock.
Synopsys Stock Down 0.1%
Synopsys stock opened at $424.32 on Wednesday. The stock has a market cap of $81.28 billion, a P/E ratio of 65.89, a P/E/G ratio of 3.45 and a beta of 1.15. The company has a quick ratio of 1.26, a current ratio of 1.36 and a debt-to-equity ratio of 0.33. Synopsys, Inc. has a twelve month low of $365.74 and a twelve month high of $651.73. The company’s 50-day moving average price is $469.06 and its two-hundred day moving average price is $472.50.
Wall Street Analysts Forecast Growth
SNPS has been the subject of several recent research reports. Needham & Company LLC restated a “buy” rating on shares of Synopsys in a report on Thursday, February 26th. Rosenblatt Securities cut their price target on shares of Synopsys from $560.00 to $530.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. Citigroup began coverage on Synopsys in a report on Monday, November 24th. They issued a “buy” rating and a $580.00 price objective for the company. JPMorgan Chase & Co. lifted their target price on Synopsys from $600.00 to $650.00 and gave the company an “overweight” rating in a research report on Thursday, December 11th. Finally, Bank of America raised Synopsys from an “underperform” rating to a “neutral” rating and reduced their price target for the company from $525.00 to $500.00 in a research report on Monday, December 8th. Eight analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $531.00.
Get Our Latest Analysis on Synopsys
Insider Activity
In related news, insider Janet Lee sold 250 shares of the company’s stock in a transaction dated Monday, January 12th. The shares were sold at an average price of $530.00, for a total value of $132,500.00. Following the transaction, the insider directly owned 11,959 shares in the company, valued at approximately $6,338,270. This represents a 2.05% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Shelagh Glaser sold 3,657 shares of Synopsys stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the completion of the sale, the chief financial officer owned 17,842 shares of the company’s stock, valued at $8,221,058.34. This trade represents a 17.01% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 4,157 shares of company stock worth $1,945,036 over the last 90 days. 0.56% of the stock is currently owned by corporate insiders.
Synopsys Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
See Also
- Five stocks we like better than Synopsys
- New Copper-Rich “Kraken” Zone Discovered
- Silver Is the New Oil—And the World’s Running Dry
- America’s 1776 happening again
- 3 Signs You May Want to Switch Financial Advisors
- Silver’s squeeze is tightening – opportunity forming
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
